These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3230149)

  • 1. Pharmacokinetics of iothalamate in endstage renal disease.
    Evans JR; Cutler RE; Forland SC
    J Clin Pharmacol; 1988 Sep; 28(9):826-30. PubMed ID: 3230149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of GFR in liver transplant candidates.
    Skluzacek PA; Szewc RG; Nolan CR; Riley DJ; Lee S; Pergola PE
    Am J Kidney Dis; 2003 Dec; 42(6):1169-76. PubMed ID: 14655188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory GFR measurement with cold iothalamate in adults with chronic kidney disease.
    Agarwal R
    Am J Kidney Dis; 2003 Apr; 41(4):752-9. PubMed ID: 12666061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure.
    Waaler A; Svaland M; Fauchald P; Jakobsen JA; Kolmannskog F; Berg KJ
    Nephron; 1990; 56(1):81-5. PubMed ID: 2234253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection.
    Roth S; Naber K; Scheer M; Gruenwaldt G; Lange H
    Eur J Clin Pharmacol; 1976 Sep; 10(5):357-65. PubMed ID: 789084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total clearance and extracellular volume with 125I-iothalamate in peritoneal dialysis.
    Amici G; Carniato A; Zoli P; Da Rin G; Boccaletto F; Bocci C; Palermo F
    Adv Perit Dial; 1996; 12():147-50. PubMed ID: 8865890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure.
    MacPhee IA; Spreafico S; Bewick M; Davis C; Eastwood JB; Johnston A; Lee T; Holt DW
    Kidney Int; 2000 Mar; 57(3):1164-8. PubMed ID: 10720968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of glomerular filtration rate using nonradioactive Iohexol: comparison of two one-compartment models.
    Rocco MV; Buckalew VM; Moore LC; Shihabi ZK
    Am J Nephrol; 1996; 16(2):138-43. PubMed ID: 8919230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal design of a two-sample test for assessing [125I]iothalamate plasma clearance in peritoneal dialysis.
    Thomaseth K; Amici G
    Nephrol Dial Transplant; 1998 Sep; 13(9):2265-70. PubMed ID: 9761507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of aminoguanidine in end-stage renal disease patients on hemodialysis.
    Foote EF; Look ZM; Giles P; Keane WF; Halstenson CE
    Am J Kidney Dis; 1995 Mar; 25(3):420-5. PubMed ID: 7872319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A; Eshima D
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of methods to assess kidney function in a predominantly overweight sample of patients with liver disease.
    Hudson JQ; Owens HM; Fleckenstein JF; Loveless VS; Krauss AG; Hak LJ
    Ren Fail; 2013; 35(2):249-56. PubMed ID: 23176438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hemodialysis on piperacillin pharmacokinetics.
    Heim-Duthoy KL; Halstenson CE; Abraham PA; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men.
    Singh AB; Norris K; Modi N; Sinha-Hikim I; Shen R; Davidson T; Bhasin S
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2437-45. PubMed ID: 11397836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluid distribution abnormalities and influence of hemodialysis on fluid distribution in patients on maintenance hemodialysis].
    Zuo L; Wang M; Wei H; Feng LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):467-70. PubMed ID: 16224514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of sodium iothalamate on the vascular resistance of the isolated perfused rat kidney.
    Haylor JL; el Sayed AA; el Nahas AM; Morcos SK
    Br J Radiol; 1991 Jan; 64(757):50-4. PubMed ID: 1998838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of glomerular filtration rate using technetium-99m-DTPA with differing degrees of renal function.
    Morton KA; Pisani DE; Whiting JH; Cheung AK; Arias JM; Valdivia S
    J Nucl Med Technol; 1997 Jun; 25(2):110-4. PubMed ID: 9239614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of simultaneous renal clearances of true endogenous creatinine and subcutaneously administered iothalamate in man.
    Pollock C; Gyory AZ; Hawkins T; Ross M; Ibels L
    Am J Nephrol; 1995; 15(4):277-82. PubMed ID: 7573183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.